A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the OMCL SEC filings page.
Omnicell Inc (OMCL) reported $1.2B in revenue over the twelve months to Sep 30, 2026, up 5.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue recovered, but cash generation and bottom-line earnings weakened while the balance sheet became less debt-heavy.
FY2025’s cash conversion mismatch is the clearest operating signal: operating cash flow was$127.3M against net income of$2.1M . Yet cash production deteriorated year over year: free cash flow fell42.6% and operating cash flow fell32.2% , so the gap should not be read as durable earnings strength.
The balance sheet has been materially deleveraged: long-term debt was
The revenue rebound did not produce much operating leverage: gross margin was
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Omnicell Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Omnicell Inc scores 25/100 on it among other operating companies.
Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Omnicell Inc scores 36/100 on it among other operating companies.
Omnicell Inc held more cash than long-term debt at the end of fiscal year 2025, with $196.5M of cash against $167.6M of long-term debt. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Omnicell Inc scores 83/100 among other operating companies measured the same way.
Omnicell Inc held $1.43 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.43. Liquidity ranks operating companies on that ratio, and Omnicell Inc scores 40/100 among other operating companies.
Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Omnicell Inc scores 66/100 on it among other operating companies.
Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Omnicell Inc scores 25/100 on it among other operating companies.
Omnicell Inc scores 2.24, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from a market capitalization of $1.5B against total liabilities of $742.9M. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Omnicell Inc passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Omnicell Inc reported $2.1M of net income while generating $127.3M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.
Key Financial Metrics
Earnings & Revenue
Omnicell Inc generated $307.9M in revenue in Q3 2026. This represents a decrease of 0.9% from the same quarter a year earlier. Against the prior quarter it is down 1.4%.
Omnicell Inc's EBITDA was $33.3M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 20.6% from the same quarter a year earlier. Against the prior quarter it is down 35.0%.
Omnicell Inc reported $11.0M in net income in Q3 2026. This represents an increase of 102.2% from the same quarter a year earlier. Against the prior quarter it is down 54.5%.
Omnicell Inc earned $0.24 per diluted share (EPS) in Q3 2026. This represents an increase of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 53.8%.
Cash & Balance Sheet
Omnicell Inc generated $21.7M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 17.1% from the same quarter a year earlier. Against the prior quarter it is down 63.5%.
Omnicell Inc held $314.9M in cash against $168.5M in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Omnicell Inc's gross margin was 44.8% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.2 percentage points.
Omnicell Inc's operating margin was 4.9% in Q3 2026, reflecting core business profitability. This is up 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.5 percentage points.
Omnicell Inc's net profit margin was 3.6% in Q3 2026, showing the share of revenue converted to profit. This is up 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.2 percentage points.
Omnicell Inc's quarterly ROE was 0.8% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.0 percentage points.
Capital Allocation
Omnicell Inc invested $22.4M in research and development in Q3 2026. This represents a decrease of 6.9% from the same quarter a year earlier. Against the prior quarter it is up 10.1%.
Omnicell Inc repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier.
Omnicell Inc invested $11.4M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 16.5% from the same quarter a year earlier. Against the prior quarter it is up 27.1%.
OMCL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $307.9M-0.9% | $312.2M+7.4% | $309.9M+14.9% | $314.0M+2.3% | $310.6M+10.0% | $290.6M+5.0% | $269.7M+9.6% | $306.9M+18.6% |
| Cost of Revenue | $170.0M-3.5% | $159.3M-2.2% | $169.5M+6.8% | $183.7M+11.2% | $176.1M+10.0% | $162.9M+0.3% | $158.7M+3.4% | $165.1M+7.6% |
| Gross Profit | $137.8M+2.5% | $152.9M+19.8% | $140.4M+26.5% | $130.3M-8.1% | $134.5M+10.0% | $127.7M+11.7% | $110.9M+19.8% | $141.8M+34.5% |
| R&D Expenses | $22.4M-6.9% | $20.3M-5.9% | $21.5M+4.8% | $22.6M-13.4% | $24.0M+13.2% | $21.6M+2.2% | $20.5M-6.9% | $26.0M-2.9% |
| SG&A Expenses | $100.5M-1.7% | $100.2M+2.2% | $102.0M0.0% | $107.4M+3.9% | $102.2M+8.2% | $98.0M+8.8% | $102.0M+10.4% | $103.3M+1.3% |
| Operating Income | $14.9M+81.1% | $32.4M+299.6% | $16.9Mn/m | $415K-96.7% | $8.2M+25.6% | $8.1M+151.9% | -$11.6Mn/m | $12.4Mn/m |
| EBITDA | $33.3M+20.6% | $51.2M+84.9% | $35.4M+322.9% | $20.2M-37.5% | $27.6M+3.3% | $27.7M+15.4% | $8.4Mn/m | $32.4Mn/m |
| Income Tax | $4.8M+12.2% | $9.5M+98.3% | $5.5Mn/m | $2.7M-64.9% | $4.2M+41.5% | $4.8M+7.9% | -$2.5Mn/m | $7.8Mn/m |
| Net Income | $11.0M+102.2% | $24.3M+330.7% | $11.4Mn/m | -$2.0M-112.8% | $5.5M-36.7% | $5.6M+51.0% | -$7.0Mn/m | $15.8Mn/m |
| EPS (Basic) | $0.24+100.0% | $0.53+341.7% | $0.25n/m | -$0.05-114.7% | $0.12-36.8% | $0.12+50.0% | -$0.15n/m | $0.34n/m |
| EPS (Diluted) | $0.24+100.0% | $0.52+333.3% | $0.25n/m | -$0.05-114.7% | $0.12-36.8% | $0.12+50.0% | -$0.15n/m | $0.34n/m |
| Diluted Shares (Avg) | 46M+1.2% | 46M-1.5% | 46M-1.4% | N/A | 46M-1.1% | 47M+2.1% | 47M+1.9% | N/A |
Not reported in any period shown, so not listed: Interest Expense.
OMCL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.1B+5.6% | $2.0B-6.8% | $2.0B-6.8% | $2.0B-6.9% | $1.9B-15.4% | $2.1B-6.4% | $2.2B-5.8% | $2.1B-4.8% |
| Current Assets | $784.0M+18.9% | $735.4M-12.9% | $722.3M-14.0% | $680.1M-16.6% | $659.6M-34.8% | $844.8M-15.2% | $839.7M-15.2% | $815.5M-12.1% |
| Cash & Equivalents | $314.9M+74.9% | $292.2M-26.8% | $239.2M-38.2% | $196.5M-46.8% | $180.1M-68.4% | $399.0M-28.3% | $386.8M-24.5% | $369.2M-21.1% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $98.3M-8.5% | $96.7M-8.6% | $99.2M+8.8% | $100.9M+13.8% | $107.4M+13.0% | $105.8M+13.4% | $91.1M-11.9% | $88.7M-19.5% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $737.1M-0.1% | $737.2M-0.2% | $737.3M+0.2% | $737.9M+0.4% | $737.9M+0.1% | $738.5M+0.4% | $736.0M+0.1% | $734.7M-0.1% |
| Total Liabilities | $739.6M+1.6% | $707.3M-19.8% | $747.5M-16.4% | $742.9M-15.4% | $727.7M-32.1% | $881.9M-19.0% | $894.4M-18.3% | $877.6M-15.4% |
| Current Liabilities | $473.7M+3.7% | $447.4M-24.7% | $483.0M-20.5% | $476.6M-20.0% | $456.6M-52.5% | $594.4M+46.0% | $607.5M+45.9% | $595.7M+62.0% |
| Non-Current Liabilities | $265.9M-1.9% | $259.8M-9.6% | $264.4M-7.8% | $266.3M-5.6% | $271.1M+144.8% | $287.5M-57.8% | $286.8M-57.7% | $282.0M-57.9% |
| Long-Term Debt | $168.5M+0.7% | $168.2M+0.7% | $167.9M+0.7% | $167.6M+0.7% | $167.3M | $167.0M-70.8% | $166.7M-70.8% | $166.4M-70.8% |
| Total Equity | $1.3B+7.9% | $1.3B+2.2% | $1.3B0.0% | $1.2B-0.9% | $1.2B-0.8% | $1.3B+5.1% | $1.3B+5.8% | $1.2B+4.6% |
| Retained Earnings | $431.6M+11.5% | $420.6M+10.2% | $396.3M+5.4% | $384.9M+0.5% | $387.0M+5.4% | $381.5M+6.4% | $375.9M+6.0% | $382.9M+3.4% |
Not reported in any period shown, so not listed: Accounts Receivable.
OMCL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $33.1M+16.9% | $68.3M+59.8% | $54.5M+110.2% | $30.4M-46.1% | $28.3M+24.2% | $42.8M-27.2% | $25.9M-48.1% | $56.3M+46.6% |
| Depreciation & Amortization | $18.4M-5.2% | $18.8M-4.1% | $18.6M-7.1% | $19.8M-0.8% | $19.4M-4.0% | $19.6M-5.8% | $20.0M-5.9% | $20.0M-8.1% |
| Stock-Based Compensation | $11.4M+1.8% | $12.2M+15.9% | $9.5M-11.9% | N/A | $11.2M-3.4% | $10.5M+5.0% | $10.8M+24.8% | N/A |
| Capital Expenditures | $11.4M+16.5% | $8.9M-24.1% | $12.4M+11.3% | $7.7M-15.2% | $9.8M+10.0% | $11.8M+23.3% | $11.2M+24.7% | $9.1M+0.2% |
| Free Cash Flow | $21.7M+17.1% | $59.4M+91.7% | $42.1M+185.1% | $22.6M-52.1% | $18.5M+33.3% | $31.0M-37.0% | $14.8M-64.0% | $47.2M+60.9% |
| Investing Cash Flow | -$13.1Mn/m | -$12.5Mn/m | -$15.9Mn/m | -$14.4Mn/m | -$14.3Mn/m | -$15.9Mn/m | -$15.7Mn/m | -$13.6Mn/m |
| Financing Cash Flow | -$4.9Mn/m | -$23.4Mn/m | $2.4M-40.8% | $9.1Mn/m | -$220.0M-6289.7% | -$11.5Mn/m | $4.0M-66.1% | -$234.4M-1885.5% |
| Share Buybacks | $0-100.0% | N/A | N/A | $0n/m | $61.9Mn/m | N/A | N/A | $0n/m |
Not reported in any period shown, so not listed: Dividends Paid.
OMCL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.8%+1.5pp | 49.0%+5.0pp | 45.3%+4.2pp | 41.5%-4.7pp | 43.3%0.0pp | 43.9%+2.6pp | 41.1%+3.5pp | 46.2%+5.5pp |
| Operating Margin | 4.9%+2.2pp | 10.4%+7.6pp | 5.4%+9.8pp | 0.1%-3.9pp | 2.6%+0.3pp | 2.8%+1.6pp | -4.3%+4.6pp | 4.0%+13.1pp |
| Net Margin | 3.6%+1.8pp | 7.8%+5.8pp | 3.7%+6.3pp | -0.7%-5.8pp | 1.8%-1.3pp | 1.9%+0.6pp | -2.6%+3.8pp | 5.2%+10.7pp |
| Return on Equity | 0.8%+0.4pp | 1.9%+1.4pp | 0.9%+1.5pp | -0.2%-1.4pp | 0.4%-0.3pp | 0.4%+0.1pp | -0.6%+0.8pp | 1.3%+2.5pp |
| Return on Assets | 0.5%+0.3pp | 1.2%+1.0pp | 0.6%+0.9pp | -0.1%-0.9pp | 0.3%-0.1pp | 0.3%+0.1pp | -0.3%+0.4pp | 0.8%+1.4pp |
| Current Ratio | 1.66+0.2x | 1.64+0.2x | 1.50+0.1x | 1.43+0.1x | 1.44+0.4x | 1.42-1.0x | 1.38-1.0x | 1.37-1.2x |
| Debt-to-Equity | 0.130.0x | 0.130.0x | 0.130.0x | 0.140.0x | 0.14 | 0.13-0.3x | 0.13-0.3x | 0.13-0.3x |
| Liabilities-to-Equity | 0.560.0x | 0.55-0.2x | 0.59-0.1x | 0.60-0.1x | 0.60-0.3x | 0.70-0.2x | 0.71-0.2x | 0.71-0.2x |
| Asset Turnover | 0.150.0x | 0.160.0x | 0.150.0x | 0.160.0x | 0.160.0x | 0.140.0x | 0.130.0x | 0.140.0x |
| FCF Margin | 7.0%+1.1pp | 19.0%+8.4pp | 13.6%+8.1pp | 7.2%-8.2pp | 6.0%+1.0pp | 10.7%-7.1pp | 5.5%-11.2pp | 15.4%+4.1pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Omnicell Inc OMCL | FY2025 | $1.2B | $2.1M | 0.2% | $1.5B | 46/100 |
| Teladoc Health, Inc. TDOC | FY2025 | $2.5B | -$200.3M | -7.9% | $1.4B | 41/100 |
| Certara, Inc. CERT | FY2025 | $418.8M | -$1.6M | -0.4% | $1.6B | 53/100 |
| GoodRx Holdings, Inc. GDRX | FY2025 | $796.9M | $30.4M | 3.8% | $1.0B | 57/100 |
| Omada Health, Inc. OMDA | FY2025 | $260.2M | -$12.8M | -4.9% | $775.5M | 55/100 |
| HealthStream Inc HSTM | FY2025 | $304.1M | $18.3M | 6.0% | $802.8M | 53/100 |
Where Omnicell Inc Ranks
Frequently Asked Questions
Omnicell Inc (OMCL) reported $1.2B in total revenue for fiscal year 2025. This represents a 6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Omnicell Inc (OMCL) revenue grew by 6.5% year-over-year, from $1.1B to $1.2B in fiscal year 2025.
Yes, Omnicell Inc (OMCL) reported a net income of $44.7M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $2.1M, with a net profit margin of 0.2%.
Omnicell Inc (OMCL) had EBITDA of $84.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Omnicell Inc (OMCL) had $196.5M in cash and equivalents against $167.6M in long-term debt.
Omnicell Inc (OMCL) had a gross margin of 42.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Omnicell Inc (OMCL) had an operating margin of 0.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Omnicell Inc (OMCL) had a net profit margin of 0.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Omnicell Inc (OMCL) has a return on equity of 0.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Omnicell Inc (OMCL) generated $86.9M in free cash flow during fiscal year 2025. This represents a -42.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Omnicell Inc (OMCL) generated $127.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Omnicell Inc (OMCL) had $2.0B in total assets as of fiscal year 2025, including both current and long-term assets.
Omnicell Inc (OMCL) invested $40.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Omnicell Inc (OMCL) invested $88.7M in research and development during fiscal year 2025.
Omnicell Inc (OMCL) had a current ratio of 1.43 as of fiscal year 2025, which is considered adequate.
Omnicell Inc (OMCL) had a debt-to-equity ratio of 0.14 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Omnicell Inc (OMCL) had a liabilities-to-equity ratio of 0.60 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Omnicell Inc (OMCL) had a return on assets of 0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Omnicell Inc (OMCL) trades at 34.2x earnings, its market capitalization divided by $44.7M net income, trailing 12 months to September 30, 2026. The market capitalization is $1.5B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Omnicell Inc (OMCL) trades at 1.2x sales, its market capitalization divided by $1.2B revenue, trailing 12 months to September 30, 2026. The market capitalization is $1.5B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Omnicell Inc (OMCL) has an Altman Z-Score of 2.24, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Omnicell Inc (OMCL) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Omnicell Inc (OMCL) reported $2.1M of net income while generating $127.3M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Omnicell Inc (OMCL) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.